Literature DB >> 18698189

Quality improvement in pediatric rheumatology: what do we need to do?

Murray H Passo1, Janalee Taylor.   

Abstract

PURPOSE OF REVIEW: Quality improvement is a mandate for all individuals and institutions in medicine. Quality improvement has spread to the specialty certifying boards, resident education accreditation, licensure boards, and hospital medical staff offices. This review summarizes the thrust of quality improvement, provides justification for the conduct of quality improvement work, and reviews the progress in development of quality measures in rheumatology to date. RECENT
FINDINGS: The American College of Rheumatology, quality of care, and quality measure committees have developed quality indicators for rheumatoid arthritis, gout, osteoporosis, and drug safety. Pediatric rheumatology is charged with developing quality measures for juvenile idiopathic arthritis; thus, there is a commitment to improve the processes and patient outcomes. Quality improvement science has progressed over the last decade and employs methodology that utilizes small number and rapid improvement cycles. Examples of this quality improvement methodology are elaborated in this review.
SUMMARY: The review summarizes the history and current mandates for quality improvement in the medical community, progress made in the development of quality measures for adult rheumatologic conditions, and preliminary quality measures for juvenile idiopathic arthritis, and cites examples of quality improvement in progress in the pediatric rheumatology.

Entities:  

Mesh:

Year:  2008        PMID: 18698189     DOI: 10.1097/BOR.0b013e32830c690f

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  7 in total

Review 1.  Improving care delivery and outcomes in pediatric rheumatic diseases.

Authors:  Julia G Harris; Catherine A Bingham; Esi M Morgan
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

2.  Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.

Authors:  Daniel J Lovell; Murray H Passo; Timothy Beukelman; Suzanne L Bowyer; Beth S Gottlieb; Michael Henrickson; Norman T Ilowite; Yukiko Kimura; Esi Morgan DeWitt; Jill Segerman; Leonard D Stein; Janalee Taylor; Richard K Vehe; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

Review 3.  Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus.

Authors:  Jianghong Deng; Nathalie E Chalhoub; Catherine M Sherwin; Caifeng Li; Hermine I Brunner
Journal:  Semin Arthritis Rheum       Date:  2019-03-16       Impact factor: 5.532

4.  Improvement in medication education in a pediatric subspecialty practice.

Authors:  Aarat M Patel; Kathryn S Torok; Paul Rosen
Journal:  Pediatr Rheumatol Online J       Date:  2010-09-15       Impact factor: 3.054

5.  Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records.

Authors:  Michael L Miller; Jason Ruprecht; Deli Wang; Ying Zhou; George Lales; Sean McKenna; Marisa Klein-Gitelman
Journal:  Pediatr Rheumatol Online J       Date:  2011-04-14       Impact factor: 3.054

Review 6.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

7.  Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

Authors:  Claas H Hinze; Dirk Holzinger; Elke Lainka; Johannes-Peter Haas; Fabian Speth; Tilmann Kallinich; Nikolaus Rieber; Markus Hufnagel; Annette F Jansson; Christian Hedrich; Hanna Winowski; Thomas Berger; Ivan Foeldvari; Gerd Ganser; Anton Hospach; Hans-Iko Huppertz; Kirsten Mönkemöller; Ulrich Neudorf; Elisabeth Weißbarth-Riedel; Helmut Wittkowski; Gerd Horneff; Dirk Foell
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-22       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.